UBS’s Calpine Corporation CPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.21M Buy
101,800
+98,500
+2,985% +$2.23M ﹤0.01% 2816
2014
Q2
$79K Buy
3,300
+2,000
+154% +$45.4K ﹤0.01% 6249
2014
Q1
$27K Sell
1,300
-12,200
-90% -$239K ﹤0.01% 7711
2013
Q4
$263K Buy
13,500
+11,500
+575% +$224K ﹤0.01% 4993
2013
Q3
$39K Sell
2,000
-100
-5% -$1.98K ﹤0.01% 7195
2013
Q2
$45K Buy
+2,100
New +$44K ﹤0.01% 6868

Other funds holding CPN

UBS's CPN Position: Q3 2014 in Review

UBS reduced its Calpine Corporation (CPN) stake by 3% in Q3 2014, selling an estimated $524K and leaving 742,991 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1095.

UBS first reported a position in CPN in Q2 2013 and has held it in 6 quarters since. The position peaked at $29.1M in Q2 2013. 315 funds tracked by Wall St. Rank hold CPN as of Q3 2014.

  • UBS held 742,991 shares of Calpine Corporation worth $16.1M as of Q3 2014.
  • UBS sold 23,163 Calpine Corporation shares in Q3 2014, an estimated $524K.
  • Calpine Corporation made up 0.01% of UBS's portfolio in Q3 2014, its #1095 holding.
  • UBS first reported a position in Calpine Corporation in Q2 2013 and has held it in 6 quarters since.
  • UBS's Calpine Corporation position peaked at $29.1M in Q2 2013.
  • 315 funds tracked by Wall St. Rank held Calpine Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.